Market Insider

Midday movers: Allergan, Five Below, Netflix & More

Getty Images

Take a look at some of Tuesday's midday movers:

Achillion Pharmaceuticals - The drug developer surged after the Food and Drug Administration lifted its hold on trials of its hepatitis C drug.

Allergan - The drug developer edged lower after rejecting the latest takeover bid from Valeant Pharmaceuticals, saying the $53 billion isn't even worth talking about.

Blount International - The outdoor-equipment company rose after KeyBanc upgraded its shares to a buy from hold after meeting with management.

Colgate-Palmolive - The supplier of consumer products rose after BMO Capital Markets upgraded the stock to outperform from market perform.

Five Below - The discount-store chain rose after naming's chief executive, Joel Anderson, as its president.

Francesca's Holdings - The supplier of women's apparel fell after cutting its full-year forecast.

General Motors - The auto manufacturer edged higher after Chief Executive Mary Barra told a shareholdings meeting GM does not plan any more dismissals linked to a defective ignition switch tied to at least 13 deaths.

Netflix - The provider of online entertainment advanced after Evercore Partners hikes its price target on its shares to $500 from $400.

Receptos - The biotechnology company gained after releasing positive phase 2 trial results on its multiple sclerosis drug.

3D Systems - The printer gained ground after raised its 2014 revenue outlook.

Twitter - The social-media company rose after Wells Fargo upgraded its shares to market perform from underperform.

Tyson Foods - The poultry producer declined after Credit Suisse downgraded the stock to underperform from neutral.

United Continental Holdings - The airline rose after saying its frequent-flier rewards program would be based on ticket price instead of distance flown, starting in March.

Wynn Resorts - The casino operator and competitors including MGM Resorts International and Melco Crown Entertainment fell after UBS downgraded Las Vegas Sands to neutral from buy.

Zynga - The video-game publisher rose after UBS issued a positive note and reiterated its buy rating.

(

—By CNBC's Rich Fisherman.

uestions? Comments? Email us at